Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm in Spain and my bank doesn't allow me to sell my Shares.
I've tried to open an account in TD Ameritrade or another US brokers, but all of them are blocking registration from Europe due to legislation restrictions.
I've contacted to other brokers and banks in Spain and they allow to their clients to sell (ING is one of them), not to buy. Unfortunately they don't allow the transfer of OTC stocks for new clients.
My only option is to try to make pressure to my bank, to see how is possible that others allow the sale to their clients and not them. Disgusting!
I didn't find any other bank or broker in Europe accepting my KKUR portfolio.
If somebody else has another solution to sell I will be happy to listen. Thanks in advance.
Hi Mitaly.
I am from Spain and my bank does not allow it either.
Do you know a broker to which I can transfer my titles.
In which brokers, the people that sold last days, have been able to do it.
Thanks a lot.
Fact: At $0.0023 we are 50% below fair value
We should be trading over $0.0047 according to the 47% stake that LLBO has of Cyrcadia Inc at $1/share.
People buying at current price are getting a 50% discount over people investing directly through Cyrcadia. This is unbelievable. Even Cyrcadia private investors should be buying here.
This price is pure manipulation and won't last long.
News will fall one after another.
Lucky the ones buying at these prices
They are stealing shares to people that needs the money or are obliged to sell.
Otherwise is crazy to sell so low.
Some here will win big in some months.
And some are desperate to buy more shares at an even lower price.
Rob Royea: Congratulations to our team at Cyrcadia and Area 23
https://www.facebook.com/rob.royea.1
http://clios.com/health/winners?search=FCB
Share price projections for LLBO
Did you notice the 500,000 ANTICIPATED ORDERS FOR 2017 they are claiming in their promotional video (
Cyrcadia Health wins a Clio Health Grand Award
The Area 23 advertising campaign to promote the future launch of the iTbra in Asia and the US has won another award. This time is a Clio Health Grand Award.
#ClioHealth 2017 Grand - ITBRA — THE WEARABLE THAT DETECTS CANCER by #Area23, an @FCBHealth Network Company https://t.co/IbnPnRbatc 🏆 pic.twitter.com/EYg8kUG1li
— Clio Awards (@ClioAwards) November 13, 2017
The price of LLBO is artificially lowered by very few people due to the lack of trades. The fair value of LLBO is currently at $0.0047 according to the percentage of shares that LLBO owns of Cyrcadia Inc (CI)(47% at $1).
Most of the people in this board are in green, because we bought our shares when they where in the $0.0007-$0.0015 range or we have averages below $0.02. And we're not planning to sell until this baby reaches the $0.01-$0.10 range.
The price will go up instantly as soon as we have any official good news:
- CISCO's Detected movie released to everybody in the Internet
- Cyrcadia Asia (CA) website activated (http://cyrcadia.asia/)
- iTbra Product upgrade ready for launch (app + hardware)
- Beginning of iTbra production in Asia or US
- Beginning of Asian or US market pilots in hospitals
- Deals with insurance companies
- FDA Class I clearance for OTC commercialization
- Beginning of Asian or US market pilots over-the-counter
- News coverage from media all over the world
- Marketing campaigns in media all over the world
- Quarterly revenues and/or profit margins announced
- New patents obtained by CI or CA
These news should fall one after the other during 2018 and as early as Q1.
Selling now is a non-sense for those that have waited for years or entered in the $0.0020-$0.0050 range.
Very soon, the current prices will be history. When this hits $0.024 (and it will), to buy 1,000,000 shares you will need $24.000, while not it only cost you $2.400.
Why do you think there's some people adding at these levels with no news?
IMO
- Please, keep the discussions in this board on-topic.
I remind to all of you that Jim Holmes is Chairman of the Board at Cyrcadia Health, and that LLBO is the main investor with 47% of Cyrcadia shares (our shares).
http://cyrcadiahealth.com/management/
If we consider that the updates made through the LLBO quarterly reports are insufficient, we have the right to request more information. And we should all do it to show our discontent.
Fell free to ask him any doubt you have about your investment, and share it here so we can all know:
http://www.otcmarkets.com/stock/LLBO/profile
Yes. Now all our hopes depends on how Cyrcadia Inc and Cyrcadia Asia executes in the coming months.
By the way Change, when is Cyrcadia Inc expected to have the next investor meeting?. If I remember good you went to the last one.
I hope Cyrcadia Inc updates us before that on FDA submission/approval and US launch. Not great to be invested in a company that is only obliged to give updates once per year, and has a management team that is missing in social networks and external events.
According to the latest press releases they should have presented the FDA Class I submission since many months, so approval should be very near.
Next week we should listen from LLBO: Q3 2017
I'm not expecting anything new from Jim Holmes, but who knows.
With any positive news this goes back to $0.005 instantly.
Thanks to share all that information pearsby09, we all need to be reassured from time to time.
CISCO has selected the ITbra as the perfect example of a technology that uses the full potential of the IoT to save lives. It's the first time they've paid for a documentary (Detected) to explain the process from a concept to market. CISCO's support does not end here. I think that once the iTbra is in the market they will continue to promote it. CISCO will be with us for the next few years.
In any case, the continued support from CISCO, assures us that we are going in the right direction, and that very soon we should have the results so expected by all.
Selling now it's a nonsense. The price should be over $0.0047 according to the 47% ownership that LLBO has over Cyrcadia Inc (currently raising money at $1/share). The current price is pure manipulation and should skyrocket over $0.01 with any positive news.
The two catalysts that we're waiting for are:
- approval by FDA (Class I)
- starting of sales in Asia or the US
We could have news at any time according to the deadlines set by Cyrcadia.
At this stage of the party is not the time to lose motivation!
CISCO talking again about the iTbra potential
Meet the Exec: Maciej Kranz ( Cisco's VP of Corporate Strategic Innovation)
https://newsroom.cisco.com/feature-content?type=webcontent&articleId=1888131
Cisco sponsored documentary highlights the lifesaving potential of IoT
https://newsroom.cisco.com/feature-content?type=webcontent&articleId=1887309
New article in the CISCO newsroom (although there is nothing new)
https://newsroom.cisco.com/feature-content?type=webcontent&articleId=1887309
I will republish it here once they have corrected the embed codes of the video and pictures.
The iTbra again in the press room of CISCO
OCTOBER 09, 2017
https://newsroom.cisco.com/feature-content?type=webcontent&articleId=1884696
This is a winning horse. As soon as it is approved by the FDA and marketed in the USA in the coming months, CISCO's support will be instrumental in exponentially multiplying LLBO's price.
CISCO hasn't forgotten us
For #BCAM, Cisco's @maciejkranz shares how IoT can detect breast cancer before it progresses: https://t.co/Gm7VS3aYPF #DetectedMovie pic.twitter.com/BjyeMXzb3O
— Cisco (@Cisco) October 6, 2017
I agree with you, and many others, that this is getting too long.
Maybe six more months before we get any relevant news.
But I will keep my shares until the important news arrive, and then I will see what I do. I understand that others will not be able to hold their position for so long.
I would like to know if Cyrcadia has hired new staff for this important launch phase. Also if they are trying to get new funding. They still don't have enough money to launch the product correctly in the US, even counting the contribution of Cyrcadia Asia.
I look forward to the first press release from our CEO Matt Benardis. But so far I think this is not going the right way with a CEO who does not communicate anything on social networks, and who does not make any public speech to make himself known. During this month he should be out there making speeches at multiple conferences to take advantage of the cancer awareness month. But he's missing! Why they don't hire an experienced CEO with the new cash? A person who has spent more than 10 years developing a product, I don't think is the best profile to lead the commercial launch of a new product. Time to market is key now!
Expected news in the next 12 months (order may vary):
- The Detected film produced by CISCO is made public
- Activation of the web http://cyrcadia.asia
- Completion of clinical trials and final data released.
- FDA approval (Class I)
- Cyrcadia Inc receives new financing above $2/share
- Start of the iTbra production
- Cyrcadia and Lifeline Biotechnologies update their websites
- Cyrcadia and Lifeline Biotechnologies begin to communicate again in social networks
- Publication of articles from media all over the world (top media also)
- Agreements with hospitals in Asia and the US
- Agreements with insurance companies in the US and other countries
- Cyrcadia and CISCO start their communication campaign to the media
- Public launch of the iTbra and the mobile app
- Approval of the iTbra by the regulatory authorities of Hong Kong (China)
- iTbra Launches in Hospitals in Hong Kong and other countries in Asia
- CISCO reports on how the iTbra uses its infrastructure
- Real-life case stories about how the iTbra starts saving lives
- First sales figures in Asia
- iTbra Launches in US Hospitals
- First US sales figures
- Cyrcadia Data (Ireland) reports on its activities
- Launch of iTbra Over The Counter in the US
- First sales figures Over The Counter in the US
- Approval of iTbra by the regulatory authorities of Europe
- iTbra launches in Europe
- First sales figures in Europe
- ...
All these milestones are likely to generate a press release and a price spike.
Who in their right mind is going to sell now after years of development and waiting? NOBODY!
When the news starts arriving, LLBO will become trending topic for OTC investors and the expectations can make the price increase exponentially between $0.01 and $0.10
Keep calm, ignore the provocations of some in this board and do you own due diligence!
Waiting to see what Cyrcadia and CISCO are going to do to promote the iTbra in October (US National Breast Cancer Awareness Month).
I also hope to start seeing Matt Benardis,new CEO of Cyrcadia Inc (CI) in public events trying to attract new investors. The main payments being received from Cyrcadia Asia (CA) are only $21,000 per month over the next 4 years. This money only serves to pay wages and little more. CI will need more cash to properly launch and scale the product in the US.
October will be the catalyst for what awaits us in the coming months. If we have positive news we can see the near future with optimism.
Nobody moves from here! Those who try to lower the price are getting it but will not get a relevant number of shares. As soon as we have any positive data the price will return to $0.004-$0.005.
IMPORTANT: The price is being manipulated downward, and should be at $0.0047 according to the 47% that LLBO owns from CI (currently raising money at $1/share). Any price below $0.0047 is not realistic as per the latest LLBO Q2 filling. As soon as we get FDA Class I approval, CI will start raising money at $2 or over, which will automatically raise LLBO price over $0.01. And as soon as CA starts selling in Asia we could easily see the price over $0.05 on future sales expectations.
TO SEE MY DUE DILIGENCE COMPILATION CLICK HERE
In the media (China): https://ifun01.com/NGHOGF8.html
To translate the article from the Chrome browser:
https://chrome.google.com/webstore/detail/google-translate/aapbdbdomjkkjkaonfhkkikfgjllcleb?hl=en
To translate the article from the web:
https://translate.google.com/
Voo, that's a lot of money invested in LLBO.
It also means that if the price reaches $0.02, you are a millionaire, if you aren't already.
I wish you the best of luck, because all the longs deserve it. I've been here since 2009!
We should see $0.005 again during next month, and $0.01 or over after FDA approval.
I hope this time they use the Cancer Awareness Month to start promoting the product in the US. But I would like to see Matt Benardis starting to move himself publicly. He's our man, now that Rob Royea works for Cyrcadia Asia.
LLBO <> CYRCADIA ---- DUE DILIGENCE COMPILATION ----
- LLBO owns 47% of Cyrcadia, Inc (US) and is its main investor
- LLBO owns 1.18% of Cyrcadia Asia (Hong Kong) via the 2.5% owned by Cyrcadia, Inc
- Cyrcadia claims to have 500,000 anticipated orders in 2017 (see the video below)
- The iTbra launch is expected in Asia and in the US by the beginning of 2018
- Cyrcadia has the support of CISCO through the film Detected
@HollyShorts on August 11
Haven't seen #DetectedMovie on the big screen yet? It will be screening at @HollyShorts on August 11: https://t.co/CaXMv3jsIj #HSFF17 pic.twitter.com/Md1mFU4BdJ
— Detected Movie (@detectedmovie) July 31, 2017
Many of us here have been believing in this technology for 9 years. The price is 400% above the lows of the year. Great for most of us because we are in green. This news is just another confirmation that things are moving forward. The big news we are waiting for are: FDA Class I approval for selling over-the-counter in the US, distribution agreements, and the beginning of the sales in Asia, the US, and other markets. When we see that in the coming months the current price will be a joke, and many will regret to have sold, or not having had the courage to enter at these levels.
Cyrcadia, Inc. Wins Prestigious Cannes Lions Awards
http://www.prweb.com/releases/2017/07/prweb14538444.htm
Great, more exposure!
The day the communication and commercial campaigns start the price will explode.
http://www.film-festival.org/
Catch #DetectedMovie at @RIFilmFest on August 11! Get your tickets here: https://t.co/HC4O9Zg2ok pic.twitter.com/OdLSZMKsiS
— Detected Movie (@detectedmovie) July 24, 2017
If sales are a success: over $0.10
Read my previous messages, taking into account that now it's confirmed we own 45% of Cyrcadia, Inc (US) and not the 40% stated there.
LLBO should be now at $0.004 and rise steadily in the coming months
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132386032
Sales and income projection (100K-10M units sold)
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131892724
The pros:
- LLBO stock price has increased 300% over the last three months.
- Cyrcadia has 3 patents in the US and other pending worldwide.
- The Detected movie will should be available in Internet after the summer.
- CISCO promotes Cyrcadia (iTbra) as an example of IoT/AI success but has not done a media campaign yet.
- FDA Class I approval can arrive at any time before the end of 2017.
- iTbra accuracy is higher than mamograms (87% vs. 83%)
- Cyrcadia Asia will start selling the iTbra + app by the beginning of 2018
- Cyrcadia Asia expects to screen over 3 millions women in one year.
- Cyrcadia, Inc (US) should start selling in the US by the beginning of 2018.
- Cyrcadia has hired the top healthcare advertising agency: Area 23
- The iTbra has a Class II clearance (tested on 500 patients) will be used to start selling the services through hospitals by the beginning of 2018.
- The iTbra will be sold later on as a product over-the-counter when receiving FDA Class I approval.
- The iTbra cost/year OTC should be around $200
- The iTbra cost/use though the hospital should be the same as a mamogram.
- The iTbra will help reduce 500,000 unnecessary biopsies in the US
- Cyrcadia claims to have 500,000 anticipated orders in 2017
LLBO / CYRCADIA ---- BASIC DUE DILIGENCE ----
LLBO owns 45% of Cyrcadia Health and is its main investor
Indeed! Soon this movie will be available on the Internet worldwide. That will be the moment when mass communication will begin to impact the media around the world.
CONGRATULATIONS! #HSFF17 #OfficialSelections @culdesacfilm #CustomOrder @shawnlebert @detectedmovie @adrianelliot #DriftingAway pic.twitter.com/CZ6Xtzwzy5
— HollyShorts (HSFF) (@HollyShorts) July 12, 2017
I agree Change. In addition, since a few days LLBO has $110,000 in cash and a $220,000 promissory note thanks to the sale of patents.
With that money, plus the investments and receivables stated in the Q1 filling, LLBO has enough money to pay the current $457,386 liabilities.
PR - http://www.marketwired.com/press-release/lifeline-biotechnologies-updates-pinksheets-llbo-2224617.htm
Q12017 - http://www.otcmarkets.com/financialReportViewer?symbol=LLBO&id=171880
For those who have panic to a possible reverse split, take into account that even if it happened, that won't be negative for the stock price. LLBO is the main investor in Cyrcadia with more than 45% of the shares. No further dilutions are needed for LLBO. A reverse split would simply reduce the number of outstanding shares, which would make LLBO even more attractive.
REVERSE SPLIT + DILUTION = NEGATIVE
REVERSE SPLIT + NO DILUTION = POSITIVE
The manipulators may be able to lower the price during the summer months, but they won't get many shares. People who haven't sold already, won't sell until iTbra is released in the US. No one will find a large number of shares below $0.004, which is the real value of LLBO based on its stake in Cyrcadia. The price will recover instantly after the summer.
Chartists Taking Aim at Lifeline Biotechnologies Inc (LLBO) Shares
https://aikenadvocate.com/chartists-taking-aim-at-lifeline-biotechnologies-inc-llbo-shares/260681/
Start by watching this video and then read previous messages in this board. You will find most of the answers you need
Change, as a Cyrcadia investor, do you have any idea of what is the % of CI in CA?
To know that % is also important to get a right image of the valuation of LLBO once CA starts selling. That % isn't factored in the current stock price.
Thanks sven. I simply try to be realistic with the official information I have at any time. But I don't claim to be right. My posts are just my opinion, and that of others can be as valid as mine if they are expressed with respect and citing credible sources of information.
I agree with you the value of the patents and all the money invested in trials and development over the years, should also be factored in at one point or another.
I will be happy when a listen that Cyrcadia Inc has raised new money at $2+, which would double our valuation from one day to another. If sales in Asia are a success, Cyrcadia Inc will be able to raise new money in the US more easily.
Now is not the time to go out of this success story. The best days are in front of us.
Well, this is what Jim Holmes has stated in his PR.
I'm just quoting his own words, so this is a reliable source for me.
You can read again my quotes here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132631967
This is why I used the word "minimum". Obviously the valuation with premium should be a lot higher, but that will be more realistic when we start to listen about approval and sales in future PRs.
This is what I understand from the latest PR:
http://www.marketwired.com/press-release/lifeline-biotechnologies-updates-pinksheets-llbo-2224617.htm
- Our stake in Cyrcadia Inc in now 45%, so LLBO should rise to a minimum of $0.0045